prof. dr. apr. Jan Van Bocxlaer
- ORCID iD
- 0000-0002-4505-5510
Show
Sort by
-
Population pharmacokinetics of lisinopril in hypertensive children and adolescents with normal to mildly reduced kidney function
-
- Journal Article
- A1
- open access
Building a human physiologically based pharmacokinetic model for aflatoxin B1 to simulate interactions with drugs
-
Building a physiologically based pharmacokinetic model for a carcinogenic food contaminant
-
Building a physiologically based pharmacokinetic model for a carcinogenic food contaminant
-
- Conference Paper
- C3
- open access
Determination of pharmacokinetic parameters of efavirenz an aflatoxin B1 : an approach to unravel possible interactions
-
- Journal Article
- A1
- open access
Altered intravenous drug disposition in people living with cystic fibrosis : a meta‐analysis integrating top‐down and bottom‐up data
-
- Journal Article
- A1
- open access
Unravelling the pharmacokinetics of aflatoxin B1 : in vitro determination of Michaelis-Menten constants, intrinsic clearance and the metabolic contribution of CYP1A2 and CYP3A4 in pooled human liver microsomes
-
- Journal Article
- A1
- open access
Possible mechanisms of the interplay between drugs and mycotoxins : is there a possible impact?
-
- Conference Paper
- C3
- open access
Determination of pharmacokinetic parameters of efavirenz and aflatoxin B1 : an approach to unravel possible interactions
-
High throughput analytical report writing in R : a case study of validating an LC-MS method for the quantification of amoxicillin in human plasma
-
- Conference Paper
- C3
- open access
Mycotoxin-drug interactions at the level of CYP450 enzymes
-
- Conference Paper
- C3
- open access
Determination of pharmacokinetic parameters of efavirenz and aflatoxin B1 : an approach to unravel possible interactions
-
Linking in vitro intrinsic dissolution rate and thermodynamic solubility with pharmacokinetic profiles of bedaquiline long-acting aqueous microsuspensions in rats
-
Physiologically based pharmacokinetic modelling of lisinopril in children: A case story of angiotensin converting enzyme inhibitors
-
An integrated paediatric population PK/PD analysis of dDAVP : how do PK differences translate to clinical outcomes?